210 related articles for article (PubMed ID: 20151196)
1. Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D.
Ballot C; Kluza J; Lancel S; Martoriati A; Hassoun SM; Mortier L; Vienne JC; Briand G; Formstecher P; Bailly C; Nevière R; Marchetti P
Apoptosis; 2010 Jul; 15(7):769-81. PubMed ID: 20151196
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D.
Kluza J; Gallego MA; Loyens A; Beauvillain JC; Sousa-Faro JM; Cuevas C; Marchetti P; Bailly C
Cancer Res; 2006 Mar; 66(6):3177-87. PubMed ID: 16540669
[TBL] [Abstract][Full Text] [Related]
3. Lamellarin D: a novel pro-apoptotic agent from marine origin insensitive to P-glycoprotein-mediated drug efflux.
Vanhuyse M; Kluza J; Tardy C; Otero G; Cuevas C; Bailly C; Lansiaux A
Cancer Lett; 2005 Apr; 221(2):165-75. PubMed ID: 15808402
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
6. Lamellarin D: a novel potent inhibitor of topoisomerase I.
Facompré M; Tardy C; Bal-Mahieu C; Colson P; Perez C; Manzanares I; Cuevas C; Bailly C
Cancer Res; 2003 Nov; 63(21):7392-9. PubMed ID: 14612538
[TBL] [Abstract][Full Text] [Related]
7. Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D.
Ballot C; Kluza J; Martoriati A; Nyman U; Formstecher P; Joseph B; Bailly C; Marchetti P
Mol Cancer Ther; 2009 Dec; 8(12):3307-17. PubMed ID: 19952118
[TBL] [Abstract][Full Text] [Related]
8. Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway.
Gallego MA; Ballot C; Kluza J; Hajji N; Martoriati A; Castéra L; Cuevas C; Formstecher P; Joseph B; Kroemer G; Bailly C; Marchetti P
Oncogene; 2008 Mar; 27(14):1981-92. PubMed ID: 17906690
[TBL] [Abstract][Full Text] [Related]
9. Dimethylaminopyridine derivatives of lupane triterpenoids cause mitochondrial disruption and induce the permeability transition.
Bernardo TC; Cunha-Oliveira T; Serafim TL; Holy J; Krasutsky D; Kolomitsyna O; Krasutsky P; Moreno AM; Oliveira PJ
Bioorg Med Chem; 2013 Dec; 21(23):7239-49. PubMed ID: 24156937
[TBL] [Abstract][Full Text] [Related]
10. Poisoning of mitochondrial topoisomerase I by lamellarin D.
Khiati S; Seol Y; Agama K; Dalla Rosa I; Agrawal S; Fesen K; Zhang H; Neuman KC; Pommier Y
Mol Pharmacol; 2014 Aug; 86(2):193-9. PubMed ID: 24890608
[TBL] [Abstract][Full Text] [Related]
11. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders--specificity vs. toxicity.
Morota S; Månsson R; Hansson MJ; Kasuya K; Shimazu M; Hasegawa E; Yanagi S; Omi A; Uchino H; Elmér E
Exp Neurol; 2009 Aug; 218(2):353-62. PubMed ID: 19348797
[TBL] [Abstract][Full Text] [Related]
13. Tributyltin causes cytochrome C release from isolated mitochondria by two discrete mechanisms.
Gogvadze V; Stridh H; Orrenius S; Cotgreave I
Biochem Biophys Res Commun; 2002 Apr; 292(4):904-8. PubMed ID: 11944900
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial toxicity of the phyotochemicals daphnetoxin and daphnoretin--relevance for possible anti-cancer application.
Diogo CV; Félix L; Vilela S; Burgeiro A; Barbosa IA; Carvalho MJ; Oliveira PJ; Peixoto FP
Toxicol In Vitro; 2009 Aug; 23(5):772-9. PubMed ID: 19362137
[TBL] [Abstract][Full Text] [Related]
15. Selenite sensitizes mitochondrial permeability transition pore opening in vitro and in vivo: a possible mechanism for chemo-protection.
Shilo S; Aronis A; Komarnitsky R; Tirosh O
Biochem J; 2003 Feb; 370(Pt 1):283-90. PubMed ID: 12423204
[TBL] [Abstract][Full Text] [Related]
16. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus.
Marchetti P; Zamzami N; Joseph B; Schraen-Maschke S; Méreau-Richard C; Costantini P; Métivier D; Susin SA; Kroemer G; Formstecher P
Cancer Res; 1999 Dec; 59(24):6257-66. PubMed ID: 10626821
[TBL] [Abstract][Full Text] [Related]
17. Anticancer properties of lamellarins.
Bailly C
Mar Drugs; 2015 Feb; 13(3):1105-23. PubMed ID: 25706633
[TBL] [Abstract][Full Text] [Related]
18. Another facet to the anticancer response to lamellarin D: induction of cellular senescence through inhibition of topoisomerase I and intracellular Ros production.
Ballot C; Martoriati A; Jendoubi M; Buche S; Formstecher P; Mortier L; Kluza J; Marchetti P
Mar Drugs; 2014 Jan; 12(2):779-98. PubMed ID: 24473175
[TBL] [Abstract][Full Text] [Related]
19. Role of the mitochondrial membrane permeability transition in cell death.
Tsujimoto Y; Shimizu S
Apoptosis; 2007 May; 12(5):835-40. PubMed ID: 17136322
[TBL] [Abstract][Full Text] [Related]
20. Novel substituted 1,4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria.
Perchellet EM; Wang Y; Lou K; Zhao H; Battina SK; Hua DH; Perchellet JP
Int J Oncol; 2007 Nov; 31(5):1231-41. PubMed ID: 17912452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
